BBNX vs CTVA · rev $100.3M vs P/E 42, rev $16.91B
Beta Bionics, Inc. Common Stock (BBNX) versus Corteva Inc (CTVA) — a side-by-side from cached financials, not a winner call.
Beta Bionics, Inc. Common Stock (BBNX) is a medical devices company listed on NASDAQ.
Corteva Inc (CTVA) is a agricultural inputs company listed on US.
Latest reported BBNX revenue for 2025-12-31 was $100.3M. Net income was -$73.2M. Revenue was up 53.9% from 2024-12-31 to 2025-12-31. BBNX currently screens at market cap $640.8M.
Latest reported CTVA revenue for 2024-12-31 was $16.91B. Net income was $919.0M. Revenue was down 1.8% from 2023-12-31 to 2024-12-31. CTVA currently screens at market cap $51.52B and trailing P/E 41.6.
BBNX currently screens at market cap $640.8M. CTVA currently screens at market cap $51.52B and trailing P/E 41.6.
Not investment advice. Open the BBNX and CTVA stock pages for the full models.
Not investment advice.